IL17A rs2275913 polymorphism and features of immunological parameters in patients with persistent allergic rhinitis during allergen-specific immunotherapy

Cover Page

Cite item

Abstract

Allergic rhinitis (AR) represents a global healthcare challenge. Epidemiology data demonstrate that around 20% of all-age group subjects suffer from allergic rhinitis. Over the last decades, AR incidence and morbidity have been markedly increased due to poorly understood causes. For instance, in the last decade AR prevalence has been elevated by 2-fold in Uzbekistan. However, medical records related to AR prevalence based on patient visit rate infer that it is dozens of times lower than actual data and reflects in no way severity of the problem, but sufficient enough to outline its large-scale spread. Allergen-specific immunotherapy (ASIT) requiring further development and adjustments represents one of the most promising approaches to treat allergic diseases. Some researchers note rise in respiratory tract allergic disease (AD) prevalence including caused by pollen allergens. Therapeutic interventions in this type of pathology emerging due to chronic inflammatory process mainly in airway mucosa are aimed at achieving good control over disease symptoms, lowering risk of subsequent exacerbations and preventing AD aggravation. IL-17 belongs to the Th17 cell-derived cytokines that was described relatively recently. IL17 genes encode six proteins (molecular weight 20-30 kDa), among which IL17A and IL17F display peak sequence homology and were studied in numerous cell types. IL-17 family proteins take part in various reactions of immune response being mainly secreted by Th17 cells. It was shown that immunological mechanisms particularly mediated by cytokines such as IL-17A involved in inflammation, regeneration and fibrogenesis are crucial in progression of diverse infectious diseases.

About the authors

F. Kh. Irsalieva

Tashkent Medical Academy

Author for correspondence.
Email: fake@neicon.ru

Irsalieva Fatima Kh. - PhD, MD (Medicine), Allergist-Immunologist, Associate Professor, Department of Allergology and Immunology

100109, Tashkent, Almazar district, City of Doctors, G-30, 2в, apt 5

Phone: +99890-958-65-56

Uzbekistan

N. D. Dustbabaeva

Tashkent Institute for Advanced Training of Doctors

Email: fake@neicon.ru

Assistant Course in Clinical Allergology, Allergist-Immunologist

Tashkent

Uzbekistan

Z. S. Kamalov

Institute of Immunology and Human Genomics, Academy of Sciences of the Republic of Uzbekistan

Email: fake@neicon.ru

PhD, MD (Medicine), Professor, AllergistImmunologist, Head, Laboratory of Immunoregulation

Tashkent

Uzbekistan

Sh. Kh. Ziyadullaev

Institute of Immunology and Human Genomics, Academy of Sciences of the Republic of Uzbekistan

Email: fake@neicon.ru

PhD, MD (Medicine), AllergistImmunologist, Head of the Laboratory

Tashkent

Uzbekistan

N. F. Nurmatova

Tashkent Medical Academy

Email: fake@neicon.ru

PhD, MD (Medicine), Pediatrician-Allergist, Associate Professor, Department of Childrens Diseases
No. 1

Tashkent

Uzbekistan

Zh. Kh. Akhmedov

LLC “Granat Stom”

Email: fake@neicon.ru

Dentist

Nazarbek village

Uzbekistan

References

  1. Бережная Н.М. Интерлейкин 25 (IL-17E): Виновник аллергии и противник рака // Цитокины и воспаление, 2010. Т. 9, № 3. С. 3-14. [Berezhnaya N.M. Interleukin 25 (IL-17E): the culprit of the allergy and the adversary of cancer. Tsitokiny i vospalenie = Cytokines and Inflammation, 2010, Vol. 9, no. 3, pp. 3-14. (In Russ.)]
  2. Борисова А.И., Каримов Д.О., Идиятулина Э.Ф., Кутлина Т.Г., Валова Я.В., Муххамадиева Г.Ф., Нуртдинова Г.М. Ассоциация полиморфного локуса rs3939286 гена IL-33 с риском развития и степенью тяжести бронхиальной астмы // Российский иммунологический журнал, 2018. Т. 12, № 4. С. 612-614. [Borisova A.I., Karimov D.O., Idiyatulina E.F., Kutlina T.G., Valova Ya.V., Mukhamadieva G.F., Nurtdinova G.M. Association of the polymorphic locus rs3939286 of the IL-33 gene with a risk of development and severity of bronchial asthma. Rossiyskiy immunologicheskiy zhurnal = Russian Journal of Immunology, 2018, Vol. 12, no. 4, pp. 612-614. (In Russ.)]
  3. Гущин И.С. Аллергенспецифическая иммунотерапия атопических заболеваний: пособие для врачей. М., 2002, 32 с. [Gushchin I.S. Allergen-specific immunotherapy of atopic diseases: a guide for doctors]. Moscow, 2002. 32 p.
  4. Костарева О.С. Интерлейкин-17: функциональные и структурные особенности // Успехи биологической химии, 2019. Т. 59. С. 393-418. [Kostareva O.S. Interleukin-17: functional and structural features. Uspekhi biologicheskoy khimii = Advances in Biological Chemistry, 2019, Vol. 59, pp. 393-418. (In Russ.)]
  5. Максимова Ю.В., Свечникова Е.В., Максимов В.Н., Колесник К.Н., Алешкина А.В., Акиншина Е.И., Немчанинова О.Б. Полиморфизм некоторых генов иммунного ответа при атопическом дерматите // Клиническая дерматология и венерология, 2015. Т. 14, № 5. С. 24-27. [Maksimova Yu.V., Svechnikova E.V., Maksimov V.N., Kolesnik K.N., Aleshkina A.V., Akinshina E.I., Nemchaninova O.B. Polymorphism of some genes of the immune response in atopic dermatitis. Klinicheskaya dermatologiya i venerologiya = Clinical Dermatology and Venereology, 2015, Vol. 14, no. 5, pp. 24-27. (In Russ.)]
  6. Чередниченко А.А., Трифонова Е.А., Вагайцева К.В., Бочарова А.В., Степанов В.А. Связь полиморфизма генов цитокинов и их рецепторов в популяциях человека с климатическими и географическими факторами // Генетика, 2014. Т. 50, № 10. С. 1254-1258. [Cherednichenko A.A., Trifonova E.A., Vagaitseva K.V., Bocharova A.V., Stepanov V.A. The relationship of polymorphism of cytokine genes and their receptors in human populations with climatic and geographical factors. Genetika = Russian Journal of Genetics, 2014, Vol. 50, no. 10, pp. 1254-12548. (In Russ.)]
  7. Фрейдин М.Б., Брагина Е.Ю., Федорова О.С., Деев И.А., Куликов Е.С., Огородова Л.М., Пузырев В.П. Полногеномный анализ ассоциаций аллергических заболеваний с молекулярными маркерами у русских жителей Западной Сибири // Молекулярная биология, 2011. Т. 45, № 3. С. 464-472. [Freidin M.B., Bragina E.Yu., Fedorova O.S., Deev I.A., Kulikov E.S., Ogorodova L.M., Puzyrev V.P. Full genome analysis of associations of allergic diseases with molecular markers in Russian residents of Western Siberia. Molekulyarnaya biologiya = Molecular Biology, 2011, Vol. 45, no. 3, pp. 464-472. (In Russ.)]
  8. Akbulut U.E., Emeksiz H.C., Citli S., Cebi A.H., Korkmaz H.A.A., Baki G. IL-17A, MCP-1, CCR-2, and ABCA1 polymorphisms in children with non-alcoholic fatty liver disease. Jornal de Pediatria (VersãoemPortuguês), 2019, Vol. 95, no. 3, pp. 350-357.
  9. Akdis M., Akdis C.A. Mechanisms of allergen-specific immunotherapy. J. Allergology Clin. Immunol., 2007, Vol. 119, Iss. 4, pp. 780-789.
  10. Arisawa T., Tahara T., Shibata T., Nagasaka M., Nakamura M., Kamiya Y., Fujita H., Nakamura M., Yoshioka D., Arima Y., Okubo M., Hirata I., Nakano H. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J. Clin. Immunol., 2008, Vol. 28, pp. 44-49.
  11. Andersson T.N., Ekman G. J., Gronlund H., Buentke E., Eriksson T.L.J., Scheynius A., van Hage-Hamsten M., Gafvelin G. A noveladjuvant-allergen complex, CBP – r Fel d 1, induces up-regulation of CD86 expression and enhances cytokine release by human dendritic cells in vitro. Immunology, 2004, Vol. 113, no. 2, pp. 253-259.
  12. Arshad S.H. Primary prevention of asthma and allergy. J. Allergy Clin. Immunol., 2005, Vol. 116, pp. 3-14.
  13. Brożek J.L., Bousquet J., Baena-Cagnani C.E., Bonini S., Canonica G.W., Casale T.B., Schünemann H.J. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J. Allergy Clin. Immunol., 2010, Vol. 126, no. 3, pp. 466-476.
  14. Canonica W., Baena-Cagna C.E., Bousquet J., Bousquet P.J., Lockey R.F., Malling H.-J., Passalacqua G., Potter P., Valovirta E. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. Allergy, 2007, Vol. 62, pp. 317-324.
  15. Chen J., Deng Y., Zhao J., Zhengxiu L., Wansheng P., Juan Y., Luo R., Lijia W., Zhou F., Xiqiang Y., Enmei L. The polymorphism of IL-17 G-152A was associated with childhood asthma and bacterial colonization of the hypopharynx in bronchiolitis. J. Clin. Immunol., 2010, Vol. 30, pp. 539-545.
  16. Ciprandi G., Marseglia G.L., Tosca M.A. Allergen-specific immunotherapy: an update on immunological mechanisms of action. Monaldi Arch. Chest. Dis., 2006, Vol. 65, no. 1, pp. 34-37.
  17. Ciprandi G., Fenoglio D., de Amici M., Quaglini S., Negrini S., Filaci G. Serum IL-17 levels in patients with allergic rhinitis. J. Allergy Clin. Immunol., 2008, Vol. 122, no. 3, pp. 650-651.e2.
  18. Chen J.H., Qin L., Shi Y.Y., Feng J.T., Zheng Y.L., Wan Y.F., Hu C.P. IL-17 protein levels in both induced sputum and plasma are increased in stable but not acute asthma individuals with obesity. Respir. Med., 2016, Vol. 121, pp. 48-58.
  19. Du J., Han J.C., Zhang Y.J., Qi G.B., Li H.B., Zhang Y.J., Cai S. Single-nucleotide polymorphisms of IL-17 gene are associated with asthma susceptibility in an Asian population. Med. Sci. Monit., 2016, Vol. 22, pp. 780-787.
  20. Doe C., Bafadhel M., Siddiqui S., Desai D., Mistry V., Rugman P., Anderson I.K. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest, 2010, Vol. 138, no. 5, pp. 1140-1147.
  21. Elfasakhany F.M., Eldamarawi M.A., Khalil A.E. Association between interleukin-17 gene polymorphism and rheumatoid arthritis among Egyptians. Meta Gene, 2018, Vol. 16, pp. 226-229.
  22. Fujisawa T., Nagao M., Hiraguchi Y., Hosoki K., Tokuda R., Usui S., Masuda S., Shinoda M., Hashiguchi A., Yamaguchi M. Biomarkers for allergen immunotherapy in cedar pollinosis. Allergology Int., 2009, Vol. 58, no. 2, pp. 163-170.
  23. Grzela K., Grzela T., Lazarczyk M., Korczak-Kowalska G., Wierzbicki P., Zawadzka-Krajewska A., Jozwiak J., Skopiñski P. Influence of allergen-specific immunotherapy on IL-4-dependent IL-12 production by monocytes. Int. J. Mol. Med., 2002, Vol. 10, pp. 481-484.
  24. Irsalieva F., Razikova I., Kamalov Z., Dustbabayeva N., Nizamov K. Rationale for sublingual allergen-specific immunotherapy in immunocompromised patients. Int. J. Pharmaceutical Res., 2020, Vol. 12, Iss. 2, pp. 230-236.
  25. Jacobi H., Poulsen L.K., Reimert C.M. IL-8 and the activation of eosinophils and neutrophils following nasal allergen challenge. Int. Arch. Allergy Immunol. 1998, Vol. 116, pp. 53-59.
  26. Jutel M., Akdis M., Blaser K., Akdis C.A. Mechanisms of allergen specific immunotherapy – T-cell tolerance and more. Allergy, 2006, Vol. 61, no. 7, pp. 796-807.
  27. Khaitova N.M., Ziyadullaev S.K., Mukhamedov R.S. Investigation of association between bronchial asthma and gene FcεRIβ 109 C/T polymorphism in Uzbek population. Med. Health Sci. J., 2011, Vol. 8, no. 4, pp. 55-58.
  28. Kohyama K., Abe S., Kodaira K., Yukawa T., Hozawa S., Sagara H., Kurosawa M. IL-13 and IL-17A gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease. Ann. Allergy Asthma Immunol., 2011, Vol. 107, no. 6, pp. 510-516.
  29. Li Z., Liu Y., Cao D., Jiang M., Luo F. IL-17A and IL-17F polymorphisms and gastric cancer risk: a metaanalysis. Genet. Mol. Res., 2015, Vol. 14, pp. 7008-7017.
  30. Moverare R. Allergen-specific increase in interleukin (IL)-4 and IL-5 secreation from peripheral blood mononuclear cells during brich-pollen immunotherapy. Allergy, 2007, Vol. 53, Iss. 3, pp. 275-281.
  31. Narbutt J., Wojtczak M., Zalinska A. The A/A genotype of an interleukin-17A polymorphism predisposes to increased severity of atopic dermatitis and coexistence with asthma. Clin. Exp. Dermatol., 2015, Vol. 40, pp. 11-16.
  32. Onishi R.M., Gaffen S.L. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology, 2009, Vol. 129, no. 3, pp. 311-321.
  33. Park H.S. Clinical and immunologic changes after allergen immunotherapy with Hop Japanese pollen. Ann. Allergy Asthma Immunol., 2001, Vol. 86, no. 4, pp. 444-448.
  34. Silny W. Effectiveness of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part III. Serum concentrations of selected immunologic parameters. Wiadomoscilekarskie, 2005, Vol. 58, no. 5-6, pp. 287-294.
  35. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGF beta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity, 2006, Vol. 24, pp. 179-189.
  36. Wang J.Y., Lin C.G., Bey M.S., Wang L., Lin F.Y.-F., Huang L., Wu L.S.-H. Discovery of genetic difference between asthmatic children with high IgE level and normal IgE level by whole genome linkage disequilibrium mapping using 763 autosomal STR markers. J. Human Genetics, 2005, Vol. 50, pp. 249-258.
  37. Zhai C., Li S., Feng W., Shi W., Wang J., Wang Q., Li M. Association of interleukin-17a rs2275913 gene polymorphism and asthma risk: a meta-analysis. Archivesofmedicalscience: AMS, 2018, Vol. 14, no. 6, pp. 1204-1211.
  38. Zhu M., Wang T., Chen R., Wang C., Liu S., Ji Y. Association between interleukin 17a gene polymorphisms and asthma risk: a meta-analysis. Asian Pac. J. Allergy Immunol., 2016, Vol. 34, no. 2, pp. 115-123.

Copyright (c) 2020 Irsalieva F.K., Dustbabaeva N.D., Kamalov Z.S., Ziyadullaev S.K., Nurmatova N.F., Akhmedov Z.K.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Свидетельство о регистрации СМИ ПИ № 77 - 11525 от 04.01.2002 выдано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies